Colgate-Palmolive (CL) has seen mixed reception from different investment groups and firms. Notable transactions include Radnor Capital Management lowering their stake and Sarasin & Partners, Summit Global Investments, and Centre Asset Management selling off shares of CL. Other investment entities, such as Capital Asset Advisory Services, Bath Savings Trust, and Annex Advisory Services, have increased their holdings, highlighting a clear difference in investment strategies and views of CL. Meanwhile, CL has been dubbed a 'recession-resistant winner' by Jim Cramer, and is among defensive stocks being betted on by billionaire Ken Fisher. Nevertheless, CL has underperformed according to some in the consumer staples sector. The performance of their pet nutrition sector has begun to stand out as a potential asset, with the suggestion of a 'Strong Buy'. Their skincare line is also posing as an attractive investment according to hedge funds. However, CL's stocks did experience a crash and missed their Q4 revenue estimates. Despite this, CL remains a favorable entity for dividend stocks. And while their shares are believed to be below their intrinsic value estimate, the company recently announced an agreement to acquire Prime100.
Colgate-Palmolive Company CL News Analytics from Tue, 14 Jan 2025 08:00:00 GMT to Sat, 07 Jun 2025 10:59:18 GMT -
Rating -2
- Innovation 3
- Information 8
- Rumor -4
